“Potential Activities of Synovial Immune Response Suppression as JNK Pathway Inhibitor in Osteoarthritis Management”, JIMKI, vol. 8, no. 2, pp. 88–94, Aug. 2020, doi: 10.53366/jimki.v8i2.128.